Autocamtide-2-relatedy peptide, myristoylated Inhibitor

CaM kinase II inhibitor; enhanced cell permeable derivative of Autocamtide-2-related inhibitory peptide (Cat No. 1688). Pretreatment,blocks reinstatement of morphine-seeking behavior in vivo.

Laabich et al (2000) Neuroprotective effect of AIP on N-methyl-D-aspartate-induced cell death in retinal neurons. Brain Res.Mol. Brain Res. 85 32 PMID:
Laabich et al (2000) Neuroprotective effect of AIP on N-methyl-D-aspartate-induced cell death in retinal neurons. Brain Res.Mol. Brain Res. 85 32 PMID:
Liu et al (2012) Inhibition of CaMKII activity in the nucleus accumbens shell blocks the reinstatement of morphine-seeking behavior in rats. Neurosci.Lett. 518 167 PMID:
Liu et al (2012) Inhibition of CaMKII activity in the nucleus accumbens shell blocks the reinstatement of morphine-seeking behavior in rats. Neurosci.Lett. 518 167 PMID:
Ishida et al (1995) A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II. Biochem. Biophys.Res.Commun. 212 806 PMID:
Ishida et al (1995) A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II. Biochem. Biophys.Res.Commun. 212 806 PMID:

Small volumes of Autocamtide-2-relatedy peptide, myristoylated, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5763919 is an inhibitor targeting Autocamtide-2-relatedy peptide, myristoylated. Also known as Autocamtide-2-related inhibitory peptide, myristoylated.